April 29, 2025
Six modules
Online | Free
More information – Ecraid
Adaptive trial designs offer a compelling alternative where trial parameters can be modified during the trial, based on pre-specified rules, to respond to emerging research findings.
The European Clinical Research Alliance on Infectious Diseases (Ecraid) has embraced adaptive trial designs as a tool for facilitating faster, more efficient, and higher-quality clinical research. The ground-breaking trials REMAP-CAP and RECOVERY both achieved unmatched speed and efficiency thanks to their adaptive platform design.
- Module 1: General introduction to Ecraid and adaptive trial designs
- Module 2: Seamless trial designs & endpoint selection
- Module 3: Group sequential designs and sample size re-estimation
- Module 4: Response adaptive randomisation and covariate-adjusted response adaptive randomisation designs
- Module 5: Platform trials and the personalised randomised controlled trial
- Module 6: Ethical and logistical concerns for adaptive designs, and CME test
ERS is one of 19 partners in the European Clinical Research Alliance on Infectious Diseases (Ecraid) consortium. Ecraid has launched a new educational series, the Ecraid training modules on adaptive clinical trial designs.